-
Autor
Birn, Henrik 1 Capasso, Giovambattista 1 Cornec-Le Gall, Emilie 1 Devuyst, Olivier 1 Gansevoort, Ron T 1 Guirchoun, Patrick 1 Harris, Tess 1 Hoorn, Ewout J 1 Knoers, Nine V A M 1 Korst, Uwe 1 Le Meur, Yannick 1 Mekahli, Djalila 1 Messchendorp, A Lianne 1 Müller, Roman-Ulrich 1 Nijenhuis, Tom 1 Ong, Albert C M 1 Sayer, John A 1 Schaefer, Franz 1 Servais, Aude 1 Tesar, Vladimir 1
-
Pracoviště
Academic Nephrology Unit Department o... 1 Association PolyKystose France Saclay... 1 Biogem Institute for Molecular Biolog... 1 CECAD University of Cologne Faculty o... 1 Department 2 of Internal Medicine and... 1 Department Genetics University Medica... 1 Department of Genetics University Med... 1 Department of Internal Medicine Divis... 1 Department of Nephrology 1st Faculty ... 1 Department of Nephrology Hemodialysis... 1 Department of Nephrology Radboud Inst... 1 Department of Nephrology University M... 1 Department of Pediatric Nephrology an... 1 Department of Renal Medicine Aarhus U... 1 Department of Renal Medicine Universi... 1 Department of Translational Medical S... 1 Departments of Clinical Medicine and ... 1 Division of Nephrology UCL Medical Sc... 1 Division of Pediatric Nephrology Cent... 1 Inherited Kidney Diseases Nephrology ... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
-
Autor
Birn, Henrik 1 Capasso, Giovambattista 1 Cornec-Le Gall, Emilie 1 Devuyst, Olivier 1 Gansevoort, Ron T 1 Guirchoun, Patrick 1 Harris, Tess 1 Hoorn, Ewout J 1 Knoers, Nine V A M 1 Korst, Uwe 1 Le Meur, Yannick 1 Mekahli, Djalila 1 Messchendorp, A Lianne 1 Müller, Roman-Ulrich 1 Nijenhuis, Tom 1 Ong, Albert C M 1 Sayer, John A 1 Schaefer, Franz 1 Servais, Aude 1 Tesar, Vladimir 1
-
Pracoviště
Academic Nephrology Unit Department o... 1 Association PolyKystose France Saclay... 1 Biogem Institute for Molecular Biolog... 1 CECAD University of Cologne Faculty o... 1 Department 2 of Internal Medicine and... 1 Department Genetics University Medica... 1 Department of Genetics University Med... 1 Department of Internal Medicine Divis... 1 Department of Nephrology 1st Faculty ... 1 Department of Nephrology Hemodialysis... 1 Department of Nephrology Radboud Inst... 1 Department of Nephrology University M... 1 Department of Pediatric Nephrology an... 1 Department of Renal Medicine Aarhus U... 1 Department of Renal Medicine Universi... 1 Department of Translational Medical S... 1 Departments of Clinical Medicine and ... 1 Division of Nephrology UCL Medical Sc... 1 Division of Pediatric Nephrology Cent... 1 Inherited Kidney Diseases Nephrology ... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
Open Access Digital Library od 1996-01-01
PubMed
35134221
DOI
10.1093/ndt/gfab312
Knihovny.cz E-zdroje
Approval of the vasopressin V2 receptor antagonist tolvaptan-based on the landmark TEMPO 3:4 trial-marked a transformation in the management of autosomal dominant polycystic kidney disease (ADPKD). This development has advanced patient care in ADPKD from general measures to prevent progression of chronic kidney disease to targeting disease-specific mechanisms. However, considering the long-term nature of this treatment, as well as potential side effects, evidence-based approaches to initiate treatment only in patients with rapidly progressing disease are crucial. In 2016, the position statement issued by the European Renal Association (ERA) was the first society-based recommendation on the use of tolvaptan and has served as a widely used decision-making tool for nephrologists. Since then, considerable practical experience regarding the use of tolvaptan in ADPKD has accumulated. More importantly, additional data from REPRISE, a second randomized clinical trial (RCT) examining the use of tolvaptan in later-stage disease, have added important evidence to the field, as have post hoc studies of these RCTs. To incorporate this new knowledge, we provide an updated algorithm to guide patient selection for treatment with tolvaptan and add practical advice for its use.
- MeSH
- antagonisté antidiuretického hormonu farmakologie terapeutické užití MeSH
- ledviny MeSH
- lidé MeSH
- polycystické ledviny autozomálně dominantní * farmakoterapie MeSH
- tolvaptan terapeutické užití MeSH
- výběr pacientů MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.